Technology
Class-leading PlexPCR® is the engine driving the entire SpeeDx product range, utilising two proprietary technologies: PlexZyme® and PlexPrime®. This technology enables high performance and reliable multiplex qPCR compared to other probe-based methods.
PlexPlus® Technology
PlexPlus® is a next generation qPCR technology which doubles the multiplexing capacity of standard installed instruments. This is achieved by detecting multiple targets within each fluorescence channel using universal, Low- and High-temperature PlexPlus® Probes, which are switched on or off during PCR cycling. Target-dependent fluorescence is acquired at two temperatures across multiple wavelengths in real time with no cross talk between temperatures.
PlexZyme® Technology
Multiplexing Accelerated
Proprietary PlexZyme® technology provides 5-levels of specificity, market-leading multiplex performance and is the driver behind the entire SpeeDx product portfolio.
PlexPrime® Technology
Multiplex Mutation Detection
PlexPrime® is a novel method for nucleic acid amplification that creates amplicons which are distinctly different from the parent sequence. The combination of PlexPrime® and PlexZyme® technology enables multiplex mutation detection with high sensitivity and specificity.
